Medicover AB (MCOVb)

Stockholm


	Symbol		Exchange		Currency
	MCOVb		Stockholm		SEK	Real-time
	MCOVBs		BATS Europe		SEK	Delayed
	5M0B		Frankfurt		EUR	Delayed

Currency in SEK

178.2000

0.0000(0.00%)

Real-time Data10:14:59

Fair Value

Day's Range

176.8000

179.2000

52 wk Range

129.2000

206.5000

MCOVb Income Statement

Featured here, the Income Statement (earnings report) for Medicover AB, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

844.4

997.8

1,377.4

1,510.2

1,746.4

Total Revenues Growth

+25.73%

+18.17%

+38.04%

+9.64%

+15.64%

Cost Of Revenues

637.1

733.6

982.4

1,170.1

1,387

Gross Profit

207.3

264.2

395

340.1

359.4

Gross Profit Growth

+26.17%

+27.45%

+49.51%

-13.9%

+5.67%

Gross Profit Margin %

24.55%

26.48%

28.68%

22.52%

20.58%

Other Operating Expenses, Total

157.6

196.2

232.4

271.4

297.1

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+22.36%	+24.49%	+18.45%	+16.78%	+9.47%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	157.6	196.2	232.4	271.4	297.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

49.7

68

162.6

68.7

62.3

Operating Income Growth

+40%

+36.82%

+139.12%

-57.75%

-9.32%

EBIT Margin %

5.89%

6.81%

11.8%

4.55%

3.57%

Net Interest Expenses

-11.9

-17.2

-19.1

-31.8

-47

Net Interest Expenses Growth

-45.12%

-44.54%

-11.05%

-66.49%

-47.8%

Interest Expense, Total

-13.7

-18.1

-20.1

-34.5

-51.4

Interest And Investment Income

1.8

0.9

1

2.7

4.4

Other Non Operating Expenses, Total

6.6

-8.1

3.1

-0.7

1.4

EBT, Excl. Unusual Items

44.4

42.7

146.6

36.2

16.7

Gain (Loss) On Sale Of Assets

-

-

-

-

7.8

Other Unusual Items, Total

-0.8

-5.2

-

-6.3

-0.2

EBT, Incl. Unusual Items

33.3

37.3

143.8

19.5

23.6

EBT, Incl. Unusual Items Growth

+5.05%

+12.01%

+285.52%

-86.44%

+21.03%

EBT, Incl. Unusual Items Margin

3.94%

3.74%

10.44%

1.29%

1.35%

Income Tax Expense

8.6

10

37.2

5.8

5.2

Net Income to Company

24.7

27.3

106.6

13.7

18.4

Minority Interest

-2.2

-1.5

-4.8

-1.9

-0.8

Net Income

22.5

25.8

101.8

11.8

17.6

Net Income Growth

+0.9%

+14.67%

+294.57%

-88.41%

+49.15%

Net Income Margin %

2.66%

2.59%

7.39%

0.78%

1.01%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

22.5

25.8

101.8

11.8

17.6

Basic EPS - Continuing Operations

0.17

0.18

0.69

0.08

0.12

Basic EPS - Continuing Operations Growth

+0.9%

+7.86%

+277.01%

-88.44%

+48.51%

Diluted EPS - Continuing Operations

0.17

0.18

0.69

0.08

0.12

Diluted EPS - Continuing Operations Growth

+0.6%

+8.33%

+276.93%

-88.48%

+49.16%

Basic Weighted Average Shares Outstanding

133.34

141.75

148.35

148.71

149.36

Diluted Weighted Average Shares Outstanding

133.34

141.75

148.35

148.95

149.65

Dividend Per Share

-

0.07

0.12

0.12

0.12

Dividend Per Share Growth

-

-

+71.43%

0%

0%

EBITDA

85

114.4

220.6

152.7

156.3

EBITDA Growth

+35.57%

+34.59%

+92.83%

-30.78%

+2.36%

EBITDA Margin %

10.07%

11.47%

16.02%

10.11%

8.95%

EBIT